Natasha Fay Thoren
CIK: 0002070977
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XFOR
X4 Pharmaceuticals, Inc
Officer
Discretionary Trading P&L
Holdings
About Thoren Natasha Fay
Thoren Natasha Fay (SEC CIK 0002070977) files insider reports with the SEC as Chief Legal Officer of X4 Pharmaceuticals, Inc (XFOR).
Signal8 holds 2 ownership filings by Thoren Natasha Fay (1 Form 3, 1 Form 4), filed between Jun 3, 2025 and Jul 3, 2025. Those filings report 1 transaction, the latest on May 20, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Thoren Natasha Fay's filings is in BOSTON, MA.
Recent filings by Thoren Natasha Fay
- May 20, 2025: Grant or award of XFOR shares (Form 4, code A).
Other insiders filing for X4 Pharmaceuticals, Inc (XFOR)
- Craig Adam R, Executive Chairman
- KIRSKE DAVID, Chief Financial Officer
- Volpone John, President
- Gold Kelly, Director
- Bridger Gary, Director
- de Craecker Francoise, Director